Patents by Inventor Jay Wesley Chaplin

Jay Wesley Chaplin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Antigen Targeting to CD180
    Publication number: 20230113073
    Abstract: The present invention provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Application
    Filed: December 9, 2022
    Publication date: April 13, 2023
    Inventors: Edward CLARK, Jay Wesley CHAPLIN
  • Compositions and methods for antigen targeting to CD180
    Patent number: 11549102
    Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Grant
    Filed: December 31, 2019
    Date of Patent: January 10, 2023
    Assignee: University of Washington
    Inventors: Edward Clark, Jay Wesley Chaplin
  • Compositions and Methods for Antigen Targeting to CD180
    Publication number: 20200216819
    Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Application
    Filed: December 31, 2019
    Publication date: July 9, 2020
    Inventors: Edward CLARK, Jay Wesley CHAPLIN
  • Compositions and methods for antigen targeting to CD180
    Patent number: 10563179
    Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: February 18, 2020
    Assignee: University of Washington Through Its Center for Commercialization
    Inventors: Edward Clark, Jay Wesley Chaplin
  • Compositions and Methods for Antigen Targeting to CD180
    Publication number: 20190144834
    Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Application
    Filed: January 11, 2019
    Publication date: May 16, 2019
    Inventors: Edward CLARK, Jay Wesley CHAPLIN
  • Compositions and methods for antigen targeting to CD180
    Patent number: 10196614
    Abstract: The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: February 5, 2019
    Assignee: University of Washington Through its Center for Commercialization
    Inventors: Edward Clark, Jay Wesley Chaplin
  • Compositions and Methods for Antigen Targeting to CD180
    Publication number: 20150238630
    Abstract: The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Application
    Filed: September 16, 2013
    Publication date: August 27, 2015
    Inventors: Edward Clark, Jay Wesley Chaplin